{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:06:20Z","timestamp":1789549580594,"version":"build-2803163510"},"reference-count":121,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"publisher","award":["2023YFC3503200"],"award-info":[{"award-number":["2023YFC3503200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"publisher","award":["2023YFC3503203"],"award-info":[{"award-number":["2023YFC3503203"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Therapeutic failure in esophageal squamous cell carcinoma (ESCC) can arise as tumor cells and their microenvironment adapt to sustained treatment pressure. The lactate\u2013lactylation axis may connect altered metabolism with adaptive treatment responses through changes in protein and chromatin regulation. However, how this axis contributes to therapeutic adaptation in ESCC and how its mechanistic evidence should be interpreted across different biological contexts remain incompletely defined. Here, we review lactate sources, the regulatory landscape of lysine lactylation, and emerging evidence linking this axis to heterogeneous treatment responses in ESCC. Studies in ESCC implicate several lactylation-related processes in therapeutic adaptation. These include poly(ADP-ribose) polymerase 1 (PARP1) K654 lactylation in DNA damage responses, signal transducer and activator of transcription 3 (STAT3) K631 and nudix hydrolase 21 (NUDT21) K23 lactylation in programmed cell death susceptibility, and the NIPA-like domain containing 1 (NIPAL1)\u2013histone H3 lysine 18 lactylation(H3K18la) and hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) K172la axes in immune microenvironment remodeling. The strength of evidence differs across individual mechanisms. Several site-specific lactylation events have been identified in ESCC models or patient-derived specimens and supported by functional validation, whereas the role of lactylation-associated pathways in predicting immunotherapy response requires further clinical investigation. Therefore, the lactate\u2013lactylation axis is best viewed as an emerging metabolic\u2013epigenetic network that connects cellular metabolic states with adaptive treatment phenotypes rather than as a universal resistance mechanism. Integrating longitudinal clinical cohorts, multi-omics profiling, and mechanistic studies will be critical for defining how lactate\u2013lactylation signatures may support patient stratification and precision therapeutic strategies in ESCC.<\/jats:p>","DOI":"10.3390\/cancers18182991","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:58:59Z","timestamp":1789545539000},"page":"2991","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Lactate\u2013Lactylation Axis as a Metabolic\u2013Epigenetic Framework for Therapeutic Adaptation in Esophageal Squamous Cell Carcinoma"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6105-7399","authenticated-orcid":false,"given":"Jingjie","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Oncology and Hematology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyuan","family":"Cui","sequence":"additional","affiliation":[{"name":"National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy for Medical Sciences and Peking Union Medical College, Beijing 100021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6414-6645","authenticated-orcid":false,"given":"Sicong","family":"Li","sequence":"additional","affiliation":[{"name":"National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy for Medical Sciences and Peking Union Medical College, Beijing 100021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuo","family":"Li","sequence":"additional","affiliation":[{"name":"Fangshan Hospital, Beijing University of Chinese Medicine, Beijing 102400, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanye","family":"Gu","sequence":"additional","affiliation":[{"name":"Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Chen","sequence":"additional","affiliation":[{"name":"National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy for Medical Sciences and Peking Union Medical College, Beijing 100021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijing","family":"Yan","sequence":"additional","affiliation":[{"name":"National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy for Medical Sciences and Peking Union Medical College, Beijing 100021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibin","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hematology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Feng","sequence":"additional","affiliation":[{"name":"National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy for Medical Sciences and Peking Union Medical College, Beijing 100021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer","volume":"366","author":"Hulshof","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1470-2045(15)00040-6","article-title":"Neoadjuvant Chemoradiotherapy plus Surgery versus Surgery Alone for Oesophageal or Junctional Cancer (CROSS): Long-Term Results of a Randomised Controlled Trial","volume":"16","author":"Shapiro","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1200\/JCO.2018.79.1483","article-title":"Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial","volume":"36","author":"Yang","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jamasurg.2021.2373","article-title":"Long-Term Efficacy of Neoadjuvant Chemoradiotherapy plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma: The NEOCRTEC5010 Randomized Clinical Trial","volume":"156","author":"Yang","year":"2021","journal-title":"JAMA Surg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1001\/jama.2021.12836","article-title":"Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial","volume":"326","author":"Luo","year":"2021","journal-title":"JAMA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e068714","DOI":"10.1136\/bmj-2021-068714","article-title":"Sintilimab versus Placebo in Combination with Chemotherapy as First Line Treatment for Locally Advanced or Metastatic Oesophageal Squamous Cell Carcinoma (ORIENT-15): Multicentre, Randomised, Double Blind, Phase 3 Trial","volume":"377","author":"Lu","year":"2022","journal-title":"BMJ"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1200\/JCO.21.01926","article-title":"Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study","volume":"40","author":"Shen","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa2111380","article-title":"Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma","volume":"386","author":"Doki","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"100789","DOI":"10.1016\/j.esmoop.2023.100789","article-title":"How We Treat Esophageal Squamous Cell Carcinoma","volume":"8","author":"Puhr","year":"2023","journal-title":"ESMO Open"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1038\/s41591-024-03064-w","article-title":"Neoadjuvant Chemotherapy with or without Camrelizumab in Resectable Esophageal Squamous Cell Carcinoma: The Randomized Phase 3 ESCORT-NEO\/NCCES01 Trial","volume":"30","author":"Qin","year":"2024","journal-title":"Nat. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(21)01234-4","article-title":"Pembrolizumab plus Chemotherapy versus Chemotherapy Alone for First-Line Treatment of Advanced Oesophageal Cancer (KEYNOTE-590): A Randomised, Placebo-Controlled, Phase 3 Study","volume":"398","author":"Sun","year":"2021","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e7235","DOI":"10.1002\/cam4.7235","article-title":"Nivolumab plus Chemotherapy or Ipilimumab versus Chemotherapy in Patients with Advanced Esophageal Squamous Cell Carcinoma (CheckMate 648): 29-Month Follow-up from a Randomized, Open-Label, Phase III Trial","volume":"13","author":"Kato","year":"2024","journal-title":"Cancer Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1007\/s12325-025-03115-9","article-title":"First-Line Tislelizumab plus Chemotherapy for Esophageal Squamous Cell Carcinoma with Programmed Death-Ligand 1 Expression \u2265 1%: A Retrospective Analysis of RATIONALE-306","volume":"42","author":"Xu","year":"2025","journal-title":"Adv. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Barba, I., Carrillo-Bosch, L., and Seoane, J. (2024). Targeting the Warburg Effect in Cancer: Where Do We Stand?. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063142"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"103627","DOI":"10.1016\/j.ebiom.2021.103627","article-title":"Lactate in the Tumour Microenvironment: From Immune Modulation to Therapy","volume":"73","author":"Wang","year":"2021","journal-title":"EBioMedicine"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.it.2022.10.005","article-title":"Lactic Acid and Lactate: Revisiting the Physiological Roles in the Tumor Microenvironment","volume":"43","author":"Apostolova","year":"2022","journal-title":"Trends Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"216837","DOI":"10.1016\/j.canlet.2024.216837","article-title":"The Emerging Role of Lactate in Tumor Microenvironment and Its Clinical Relevance","volume":"590","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"24032","DOI":"10.1038\/s41598-025-10456-6","article-title":"Lactate-Related Gene Signatures Predict Prognosis and Immune Profiles in Esophageal Squamous Cell Carcinoma","volume":"15","author":"Wang","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s13277-012-0506-0","article-title":"LDHA Is Necessary for the Tumorigenicity of Esophageal Squamous Cell Carcinoma","volume":"34","author":"Yao","year":"2013","journal-title":"Tumor Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1074\/mcp.M112.022830","article-title":"Global and Targeted Metabolomics of Esophageal Squamous Cell Carcinoma Discovers Potential Diagnostic and Therapeutic Biomarkers","volume":"12","author":"Xu","year":"2013","journal-title":"Mol. Cell. Proteom."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/s41467-019-09179-w","article-title":"Targeting Glutamine-Addiction and Overcoming CDK4\/6 Inhibitor Resistance in Human Esophageal Squamous Cell Carcinoma","volume":"10","author":"Qie","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12943-023-01839-2","article-title":"Mechanisms of Radiotherapy Resistance and Radiosensitization Strategies for Esophageal Squamous Cell Carcinoma","volume":"22","author":"An","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic Regulation of Gene Expression by Histone Lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"ref_24","first-page":"1558","article-title":"Histone Lactylation","volume":"20","author":"Visan","year":"2019","journal-title":"Nat. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","article-title":"Lactate and Lactylation in Cancer","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"101248","DOI":"10.1016\/j.drup.2025.101248","article-title":"Lactylation in Cancer Progression and Drug Resistance","volume":"81","author":"Sun","year":"2025","journal-title":"Drug Resist. Updat."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Chen, L., Huang, L., Gu, Y., Cang, W., Sun, P., and Xiang, Y. (2022). Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911943"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1017\/erm.2022.42","article-title":"Lactate, Histone Lactylation and Cancer Hallmarks","volume":"25","author":"Lv","year":"2023","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Chang, D., Li, D., Sun, Y., Shi, J., Zhang, S., and Wang, C. (2025). Targeting Lactylation for Cancer: Mechanisms, Effects, and Therapeutic Prospects. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262311278"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e72229","DOI":"10.1096\/fj.202602899R","article-title":"Lactylation Modification and Esophageal Cancer: Research Progress From Hypoxia-Induced Metabolic Reprogramming to Immune Escape","volume":"40","author":"Liu","year":"2026","journal-title":"FASEB J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"101561","DOI":"10.1016\/j.mcpro.2026.101561","article-title":"Lactylome Reprogramming Mediates Therapeutic Response and Adaptation to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma","volume":"25","author":"Peng","year":"2026","journal-title":"Mol. Cell. Proteom."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2685912","DOI":"10.1080\/19490976.2026.2685912","article-title":"Intratumor Lactobacillus Drives Ferroptosis Resistance via D-Lactate-STAT3 K631 Lactylation in Esophageal Squamous Cell Carcinoma","volume":"18","author":"Wang","year":"2026","journal-title":"Gut Microbes"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41421-025-00804-1","article-title":"NUDT21 Lactylation Reprograms Alternative Polyadenylation to Promote Cuproptosis Resistance","volume":"11","author":"Lin","year":"2025","journal-title":"Cell Discov."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"218548","DOI":"10.1016\/j.canlet.2026.218548","article-title":"Lactylation of HIF-1\u03b1 at K172 Drives HIF-1 Complex Assembly to Promote Hypoxia-Induced Immune Evasion in Esophageal Squamous Cell Carcinoma","volume":"651","author":"Cong","year":"2026","journal-title":"Cancer Lett."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1080\/1744666X.2025.2545904","article-title":"EVA1A Facilitates Glycolysis in Esophageal Squamous Cell Carcinoma to Boost PLAU Histone Lactylation and Dampen CD8+ T Cell Activity","volume":"21","author":"Yuan","year":"2025","journal-title":"Expert Rev. Clin. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e20055","DOI":"10.1002\/advs.202520055","article-title":"NIPAL1 Drives a Metabolic-Epigenetic Feedback Loop to Promote Lactate-Mediated Immune Evasion in Esophageal Cancer","volume":"13","author":"Chen","year":"2026","journal-title":"Adv. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s10565-025-10102-x","article-title":"CBX6 Induces CD8+ T Cell Exhaustion and Tumor Development in Esophageal Squamous Cell Carcinoma through SMARCD1-Mediated CCL8 Secretion and Lactate Efflux","volume":"41","author":"Wang","year":"2025","journal-title":"Cell Biol. Toxicol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12964-025-02132-z","article-title":"L- and D-Lactate: Unveiling Their Hidden Functions in Disease and Health","volume":"23","author":"Li","year":"2025","journal-title":"Cell Commun. Signal."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2018.03.001","article-title":"How the Warburg Effect Supports Aggressiveness and Drug Resistance of Cancer Cells?","volume":"38","author":"Icard","year":"2018","journal-title":"Drug Resist. Updat."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1476-4598-12-152","article-title":"Tumor Glycolysis as a Target for Cancer Therapy: Progress and Prospects","volume":"12","author":"Geschwind","year":"2013","journal-title":"Mol. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00432-026-06517-6","article-title":"Lactylation-Augmented DCBLD1-Mediated PDIA3 Stabilization Reprograms Glycolysis Metabolism in Oesophageal Cancer","volume":"152","author":"Yin","year":"2026","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"116415","DOI":"10.1016\/j.bcp.2024.116415","article-title":"Hypoxia Exposure Induces Lactylation of Axin1 Protein to Promote Glycolysis of Esophageal Carcinoma Cells","volume":"226","author":"Li","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1007\/s11010-023-04913-x","article-title":"Hypoxia-Induced SHMT2 Protein Lactylation Facilitates Glycolysis and Stemness of Esophageal Cancer Cells","volume":"479","author":"Qiao","year":"2024","journal-title":"Mol. Cell. Biochem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","article-title":"The Reverse Warburg Effect: Aerobic Glycolysis in Cancer Associated Fibroblasts and the Tumor Stroma","volume":"8","author":"Pavlides","year":"2009","journal-title":"Cell Cycle"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.semcancer.2014.01.005","article-title":"Catabolic Cancer-Associated Fibroblasts Transfer Energy and Biomass to Anabolic Cancer Cells, Fueling Tumor Growth","volume":"25","author":"Lisanti","year":"2014","journal-title":"Semin. Cancer Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"105708","DOI":"10.1016\/j.ebiom.2025.105708","article-title":"The Metabolic Dialogue between Intratumoural Microbes and Cancer: Implications for Immunotherapy","volume":"115","author":"Situ","year":"2025","journal-title":"EBioMedicine"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"eadg2697","DOI":"10.1126\/sciadv.adg2697","article-title":"D-Lactate Modulates M2 Tumor-Associated Macrophages and Remodels Immunosuppressive Tumor Microenvironment for Hepatocellular Carcinoma","volume":"9","author":"Han","year":"2023","journal-title":"Sci. Adv."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.chom.2025.06.013","article-title":"Lactate Production by Tumor-Resident Staphylococcus Promotes Metastatic Colonization in Lung Adenocarcinoma","volume":"33","author":"Yu","year":"2025","journal-title":"Cell Host Microbe"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s13402-026-01182-w","article-title":"Lactate and Lactylation: Metabolic Architects of Tumor Progression and Metastasis","volume":"49","author":"Ma","year":"2026","journal-title":"Cell. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"eabi6696","DOI":"10.1126\/sciadv.abi6696","article-title":"Class I Histone Deacetylases (HDAC1-3) Are Histone Lysine Delactylases","volume":"8","author":"Zhang","year":"2022","journal-title":"Sci. Adv."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1111\/1759-7714.15096","article-title":"The Role of Microbiota in Esophageal Squamous Cell Carcinoma: A Review of the Literature","volume":"14","author":"Chiang","year":"2023","journal-title":"Thorac. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Li, Z., Dou, L., Zhang, Y., He, S., Zhao, D., Hao, C., Song, G., Zhang, W., Liu, Y., and Wang, G. (2021). Characterization of the Oral and Esophageal Microbiota in Esophageal Precancerous Lesions and Squamous Cell Carcinoma. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.714162"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Jiang, Z., Wang, J., Shen, Z., Zhang, Z., and Wang, S. (2021). Characterization of Esophageal Microbiota in Patients with Esophagitis and Esophageal Squamous Cell Carcinoma. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.774330"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41392-023-01555-9","article-title":"CDK7-YAP-LDHD Axis Promotes D-Lactate Elimination and Ferroptosis Defense to Support Cancer Stem Cell-like Properties","volume":"8","author":"Lv","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1186\/s12967-026-07877-w","article-title":"Lactylation and Acetylation: Parallel Paths, Divergent Deeds, and Research Dilemmas","volume":"24","author":"Jiang","year":"2026","journal-title":"J. Transl. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmet.2024.10.015","article-title":"ACSS2 Acts as a Lactyl-CoA Synthetase and Couples KAT2A to Function as a Lactyltransferase for Histone Lactylation and Tumor Immune Evasion","volume":"37","author":"Zhu","year":"2025","journal-title":"Cell Metab."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1038\/s12276-023-01095-w","article-title":"Lactate as a Major Epigenetic Carbon Source for Histone Acetylation via Nuclear LDH Metabolism","volume":"55","author":"An","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41580-025-00876-7","article-title":"Biochemistry and Regulation of Histone Lysine L-Lactylation","volume":"27","author":"Sheng","year":"2026","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s42255-025-01259-0","article-title":"The Emerging Role of Protein L-Lactylation in Metabolic Regulation and Cell Signalling","volume":"7","author":"Ren","year":"2025","journal-title":"Nat. Metab."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cmet.2024.11.005","article-title":"Nuclear GTPSCS Functions as a Lactyl-CoA Synthetase to Promote Histone Lactylation and Gliomagenesis","volume":"37","author":"Liu","year":"2025","journal-title":"Cell Metab."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e174587","DOI":"10.1172\/JCI174587","article-title":"The Alanyl-tRNA Synthetase AARS1 Moonlights as a Lactyltransferase to Promote YAP Signaling in Gastric Cancer","volume":"134","author":"Ju","year":"2024","journal-title":"J. Clin. Investig."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"100973","DOI":"10.1016\/j.mcpro.2025.100973","article-title":"SIRT3 Functions as an Eraser of Histone H3K9 Lactylation to Modulate Transcription for Inhibiting the Progression of Esophageal Cancer","volume":"24","author":"Chen","year":"2025","journal-title":"Mol. Cell. Proteom."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e2421496121","DOI":"10.1073\/pnas.2421496121","article-title":"DPF2 Reads Histone Lactylation to Drive Transcription and Tumorigenesis","volume":"121","author":"Zhai","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1016\/j.cell.2025.03.048","article-title":"Long-Term Histone Lactylation Connects Metabolic and Epigenetic Rewiring in Innate Immune Memory","volume":"188","author":"Ziogas","year":"2025","journal-title":"Cell"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"eabi8602","DOI":"10.1126\/sciadv.abi8602","article-title":"Lactate Supports a Metabolic-Epigenetic Link in Macrophage Polarization","volume":"7","author":"Noe","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/15384101.2021.2015671","article-title":"CircGOT1 Promotes Cell Proliferation, Mobility, and Glycolysis-Mediated Cisplatin Resistance via Inhibiting Its Host Gene GOT1 in Esophageal Squamous Cell Cancer","volume":"21","author":"Zhou","year":"2022","journal-title":"Cell Cycle"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1111\/cas.13995","article-title":"Glucose Transporter 1 Regulates the Proliferation and Cisplatin Sensitivity of Esophageal Cancer","volume":"110","author":"Sawayama","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"116679","DOI":"10.1016\/j.lfs.2019.116679","article-title":"ALC1 Knockdown Enhances Cisplatin Cytotoxicity of Esophageal Squamous Cell Carcinoma Cells by Inhibition of Glycolysis through PI3K\/Akt Pathway","volume":"232","author":"Li","year":"2019","journal-title":"Life Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/mc.23460","article-title":"CCT4 Knockdown Enhances the Sensitivity of Cisplatin by Inhibiting Glycolysis in Human Esophageal Squamous Cell Carcinomas","volume":"61","author":"Fang","year":"2022","journal-title":"Mol. Carcinog."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2365449","DOI":"10.1080\/15384047.2024.2365449","article-title":"Sirtuin1 (Sirt1) Regulates the Glycolysis Pathway and Decreases Cisplatin Chemotherapeutic Sensitivity to Esophageal Squamous Cell Carcinoma","volume":"25","author":"Yang","year":"2024","journal-title":"Cancer Biol. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/mc.23209","article-title":"Nicotinamide N-Methyltransferase Decreases 5-Fluorouracil Sensitivity in Human Esophageal Squamous Cell Carcinoma through Metabolic Reprogramming and Promoting the Warburg Effect","volume":"59","author":"Cui","year":"2020","journal-title":"Mol. Carcinog."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1667\/RADE-22-00126.1","article-title":"LncRNA DGCR5 Silencing Enhances the Radio-Sensitivity of Human Esophageal Squamous Cell Carcinoma via Negatively Regulating the Warburg Effect","volume":"199","author":"Wu","year":"2023","journal-title":"Radiat. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.2147\/DDDT.S370114","article-title":"Baicalein Inhibits the Progression and Promotes Radiosensitivity of Esophageal Squamous Cell Carcinoma by Targeting HIF-1A","volume":"16","author":"Guo","year":"2022","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"68170","DOI":"10.18632\/oncotarget.11906","article-title":"Diisopropylamine Dichloroacetate Enhances Radiosensitization in Esophageal Squamous Cell Carcinoma by Increasing Mitochondria-Derived Reactive Oxygen Species Levels","volume":"7","author":"Dong","year":"2016","journal-title":"Oncotarget"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.7150\/thno.41427","article-title":"Metabolic Remodeling by TIGAR Overexpression Is a Therapeutic Target in Esophageal Squamous-Cell Carcinoma","volume":"10","author":"Chu","year":"2020","journal-title":"Theranostics"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Simoni, N., Rossi, G., Benetti, G., Zuffante, M., Micera, R., Pavarana, M., Guariglia, S., Zivelonghi, E., Mengardo, V., and Weindelmayer, J. (2020). 18F-FDG PET\/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated with Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.599907"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"404","DOI":"10.21037\/tcr-2025-1-2204","article-title":"Identification of Protein Lysine Lactylation and Potential Targets in Esophageal Squamous Cell Carcinoma","volume":"15","author":"Zhang","year":"2026","journal-title":"Transl. Cancer Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"110188","DOI":"10.1016\/j.isci.2024.110188","article-title":"Hypoxia Promotes Histone H3K9 Lactylation to Enhance LAMC2 Transcription in Esophageal Squamous Cell Carcinoma","volume":"27","author":"Zang","year":"2024","journal-title":"iScience"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1186\/s12967-025-07144-4","article-title":"H2BC9 Lactylation Modulates Esophageal Squamous Cell Carcinoma Progression via the Wnt\/\u03b2-Catenin Signaling Pathway","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1080\/19768354.2024.2417458","article-title":"AP001885.4 Promotes the Proliferation of Esophageal Squamous Cell Carcinoma Cells by Histone Lactylation- and NF-\u03baB (P65)-Dependent Transcription Activation and METTL3-Mediated mRNA Stability of c-Myc","volume":"28","author":"Fu","year":"2024","journal-title":"Anim. Cells Syst."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.21037\/jgo-2024-1006","article-title":"A Novel Lactylation-Related Signature for Predicting Esophageal Cancer Prognosis and Immune Infiltration","volume":"16","author":"Xie","year":"2025","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"463","DOI":"10.21037\/tcr-2026-1-0300","article-title":"Identification of GADD45B, HMGB3, LMNB2, and MFAP5 as Lactylation-Related Prognostic Markers for Survival Prediction in Esophageal Cancer","volume":"15","author":"Li","year":"2026","journal-title":"Transl. Cancer Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12026-024-09589-z","article-title":"Integrative Bioinformatics and Experimental Analyses Identify U2SURP as a Novel Lactylation-Related Prognostic Signature in Esophageal Carcinoma","volume":"73","author":"Zheng","year":"2025","journal-title":"Immunol. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1126\/science.1216338","article-title":"Structural Basis for DNA Damage-Dependent Poly(ADP-Ribosyl)Ation by Human PARP-1","volume":"336","author":"Langelier","year":"2012","journal-title":"Science"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.celrep.2018.12.082","article-title":"Efficient Single-Strand Break Repair Requires Binding to Both Poly(ADP-Ribose) and DNA by the Central BRCT Domain of XRCC1","volume":"26","author":"Polo","year":"2019","journal-title":"Cell Rep."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1016\/j.molcel.2022.06.011","article-title":"Captured Snapshots of PARP1 in the Active State Reveal the Mechanics of PARP1 Allostery","volume":"82","author":"Krastev","year":"2022","journal-title":"Mol. Cell"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41586-024-07620-9","article-title":"NBS1 Lactylation Is Required for Efficient DNA Repair and Chemotherapy Resistance","volume":"631","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.cell.2023.11.022","article-title":"Metabolic Regulation of Homologous Recombination Repair by MRE11 Lactylation","volume":"187","author":"Chen","year":"2024","journal-title":"Cell"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1016\/j.molcel.2025.06.019","article-title":"Lactylation of XLF Promotes Non-Homologous End-Joining Repair and Chemoresistance in Cancer","volume":"85","author":"Jin","year":"2025","journal-title":"Mol. Cell"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.7150\/thno.104858","article-title":"Targeting Platinum-Resistant Ovarian Cancer by Disrupting Histone and RAD51 Lactylation","volume":"15","author":"Sun","year":"2025","journal-title":"Theranostics"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e2309290","DOI":"10.1002\/advs.202309290","article-title":"Histone H3K9 Lactylation Confers Temozolomide Resistance in Glioblastoma via LUC7L2-Mediated MLH1 Intron Retention","volume":"11","author":"Yue","year":"2024","journal-title":"Adv. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of Ferroptotic Cancer Cell Death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","article-title":"DHODH-Mediated Ferroptosis Defence Is a Targetable Vulnerability in Cancer","volume":"593","author":"Mao","year":"2021","journal-title":"Nature"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s13238-021-00841-y","article-title":"Ferroptosis, Radiotherapy, and Combination Therapeutic Strategies","volume":"12","author":"Lei","year":"2021","journal-title":"Protein Cell"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","article-title":"The Role of Ferroptosis in Ionizing Radiation-Induced Cell Death and Tumor Suppression","volume":"30","author":"Lei","year":"2020","journal-title":"Cell Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12967-021-03042-7","article-title":"SLC7A11 Regulated by NRF2 Modulates Esophageal Squamous Cell Carcinoma Radiosensitivity by Inhibiting Ferroptosis","volume":"19","author":"Feng","year":"2021","journal-title":"J. Transl. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.21873\/anticanres.18048","article-title":"Roles of GPX4 and FSP1 in Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemotherapy","volume":"46","author":"Takahashi","year":"2026","journal-title":"Anticancer Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e2408845","DOI":"10.1002\/advs.202408845","article-title":"Lactylation of HDAC1 Confers Resistance to Ferroptosis in Colorectal Cancer","volume":"12","author":"Yang","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41419-025-07498-z","article-title":"Histone Lactylation Enhances GCLC Expression and Thus Promotes Chemoresistance of Colorectal Cancer Stem Cells through Inhibiting Ferroptosis","volume":"16","author":"Deng","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e73576","DOI":"10.2196\/73576","article-title":"Prognostic Value of Dynamic Lactate Dehydrogenase Trends in Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma: Retrospective Cohort Study","volume":"12","author":"Zhang","year":"2026","journal-title":"JMIR Cancer"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/1759-7714.13083","article-title":"Lactate Dehydrogenase and Baseline Markers Associated with Clinical Outcomes of Advanced Esophageal Squamous Cell Carcinoma Patients Treated with Camrelizumab (SHR-1210), a Novel Anti-PD-1 Antibody","volume":"10","author":"Wang","year":"2019","journal-title":"Thorac. Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Li, Y., Wang, K., Zhao, E., Li, B., Li, S., Dong, X., Yuan, L., and Yang, H. (2022). Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma. Pathol. Oncol. Res., 28.","DOI":"10.3389\/pore.2022.1610245"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1073\/pnas.0914433107","article-title":"Inhibition of Lactate Dehydrogenase a Induces Oxidative Stress and Inhibits Tumor Progression","volume":"107","author":"Le","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1038\/s41590-024-01999-3","article-title":"Dysfunction of Exhausted T Cells Is Enforced by MCT11-Mediated Lactate Metabolism","volume":"25","author":"Peralta","year":"2024","journal-title":"Nat. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e007349","DOI":"10.1136\/jitc-2023-007349","article-title":"MCT4 Blockade Increases the Efficacy of Immune Checkpoint Blockade","volume":"11","author":"Babl","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"216824","DOI":"10.1016\/j.canlet.2024.216824","article-title":"Targeting Tumor-Intrinsic SLC16A3 to Enhance Anti-PD-1 Efficacy via Tumor Immune Microenvironment Reprogramming","volume":"589","author":"Yu","year":"2024","journal-title":"Cancer Lett."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1158\/1078-0432.CCR-22-2263","article-title":"A Phase I Dose-Escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer","volume":"29","author":"Halford","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1158\/1535-7163.MCT-13-1091","article-title":"Inhibition of Monocarboxylate Transporter-1 (MCT1) by AZD3965 Enhances Radiosensitivity by Reducing Lactate Transport","volume":"13","author":"Bola","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41416-019-0717-x","article-title":"Monocarboxylate Transporter 1 Blockade with AZD3965 Inhibits Lipid Biosynthesis and Increases Tumour Immune Cell Infiltration","volume":"122","author":"Wantuch","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"eadd2712","DOI":"10.1126\/scitranslmed.add2712","article-title":"Lactate Oxidase Nanocapsules Boost T Cell Immunity and Efficacy of Cancer Immunotherapy","volume":"15","author":"Cao","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nature24028","article-title":"Discovery of a Selective Catalytic P300\/CBP Inhibitor That Targets Lineage-Specific Tumours","volume":"550","author":"Lasko","year":"2017","journal-title":"Nature"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1021\/acsmedchemlett.0c00155","article-title":"Discovery of CPI-1612: A Potent, Selective, and Orally Bioavailable EP300\/CBP Histone Acetyltransferase Inhibitor","volume":"11","author":"Wilson","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.molcel.2021.04.015","article-title":"Targeting Histone Acetylation Dynamics and Oncogenic Transcription by Catalytic P300\/CBP Inhibition","volume":"81","author":"Hogg","year":"2021","journal-title":"Mol. Cell"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"102317","DOI":"10.1016\/j.redox.2022.102317","article-title":"Inhibition of STAT3-Ferroptosis Negative Regulatory Axis Suppresses Tumor Growth and Alleviates Chemoresistance in Gastric Cancer","volume":"52","author":"Ouyang","year":"2022","journal-title":"Redox Biol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/s43018-025-00937-y","article-title":"Palmitoylation of GPX4 via the Targetable ZDHHC8 Determines Ferroptosis Sensitivity and Antitumor Immunity","volume":"6","author":"Zhou","year":"2025","journal-title":"Nat. Cancer"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41467-025-56344-5","article-title":"Palmitoylation-Dependent Regulation of GPX4 Suppresses Ferroptosis","volume":"16","author":"Huang","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e2315541121","DOI":"10.1073\/pnas.2315541121","article-title":"USP8-Governed GPX4 Homeostasis Orchestrates Ferroptosis and Cancer Immunotherapy","volume":"121","author":"Li","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"9097","DOI":"10.1038\/s41467-024-52977-0","article-title":"Single-Cell Sequencing Reveals Immune Features of Treatment Response to Neoadjuvant Immunochemotherapy in Esophageal Squamous Cell Carcinoma","volume":"15","author":"Yang","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/dmcn.16252","article-title":"Safety and Effectiveness of Stiripentol in Patients with Dravet Syndrome: A Prospective, 3-Year, Postmarketing Surveillance Study","volume":"67","author":"Kitamura","year":"2025","journal-title":"Dev. Med. Child Neurol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1200\/jco.2010.28.15_suppl.3076","article-title":"Results from a Phase I, Dose-Escalation Study of PX-478, an Orally Available Inhibitor of HIF-1\u03b1","volume":"28","author":"Tibes","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"025003","DOI":"10.1088\/2632-072X\/ae5864","article-title":"Combination of TRAIL-Producing Oncolytic Virus and PAC-1 for Treatment of Granulosa Cell Tumours of the Ovary","volume":"7","author":"Nave","year":"2026","journal-title":"J. Phys. Complex."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/18\/2991\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:19:25Z","timestamp":1789546765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/18\/2991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":121,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cancers18182991"],"URL":"https:\/\/doi.org\/10.3390\/cancers18182991","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]}}}